WHO 2021 recommends screening for tuberculosis with urine lipoarabinomannan (LAM) for inpatients (CD4 +  < 200 cells/mm3) or outpatients (CD4 +  < 100 cells/mm3), any CD4 count with symptoms, or if seriously ill. This evidence concerns the gene CD4 and tuberculosis.